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Abstract
Human cytomegalovirus (HCMV) UL77 gene encodes the essential protein UL77, its function is characterized in the present
study. Immunoprecipitation identified monomeric and oligomeric pUL77 in HCMV infected cells. Immunostaining of
purified virions and subviral fractions showed that pUL77 is a structural protein associated with capsids. In silico analysis
revealed the presence of a coiled-coil motif (CCM) at the N-terminus of pUL77. Chemical cross-linking of either wild-type
pUL77 or CCM deletion mutant (pUL77DCCM) implicated that CCM is critical for oligomerization of pUL77. Furthermore, co-
immunoprecipitations of infected and transfected cells demonstrated that pUL77 interacts with the capsid-associated DNA
packaging motor components, pUL56 and pUL104, as well as the major capsid protein. The ability of pUL77 to bind dsDNA
was shown by an in vitro assay. Binding to certain DNA was further confirmed by an assay using biotinylated 36-, 250-, 500-,
1000-meric dsDNA and 966-meric HCMV-specific dsDNA designed for this study. The binding efficiency (BE) was determined
by image processing program defining values above 1.0 as positive. While the BE of the pUL56 binding to the 36-mer bio-
pac1 containing a packaging signal was 10.060.63, the one for pUL77 was only 0.260.03. In contrast to this observation the
BE of pUL77 binding to bio-500 bp or bio-1000 bp was 2.260.41 and 4.960.71, respectively. By using pUL77DCCM it was
demonstrated that this protein could not bind to dsDNA. These data indicated that pUL77 (i) could form homodimers, (ii)
CCM of pUL77 is crucial for oligomerization and (iii) could bind to dsDNA in a sequence independent manner.
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Introduction
The assembly of most double-stranded tailed bacteriophages
and herpesviruses is a common, multistep process during viral
maturation. The concatemeric, newly synthesized DNA has to be
cleaved into unit-length genomes prior to packaging into empty
capsids and condensed into a structure of near crystalline density.
Enzymes involved in this process are responsible for site-specific
cleavage and insertion of the DNA into the procapsid [1,2]. These
enzymes known as terminases power the packaging via their
ATPase activity. In previous studies we have demonstrated that
the HCMV terminase consists of two subunits, the large one
encoding pUL56 and the small one pUL89 [3–6], whereas each
subunit has a different function. HCMV pUL56 is required for
recognition and binding to DNA at specific sequence motifs
(packaging signals, e.g. pac1 and pac2), it mediates interaction of
the DNA-protein-complex with the portal protein pUL104 and
catalyzes the import of one unit-length genome into the capsid by
providing ATP [5–8]. The small subunit pUL89 is required for the
completion of the packaging process by cleavage of concatemeric
DNA into unit-length genomes (two strand nicking; 9). The
terminase together with the portal protein pUL104 [10,11] form
the molecular nanomotor which enables the insertion of the viral
genome into capsids against growing internal forces [12]. Smith
et al. (2001) have demonstrated that forces during packaging of
bacteriophage phi can increase to 57 pico Newton (pN), thus
representing one of the strongest biological nanomotors [13].
In addition to the terminase subunits and the portal protein
Borst et al. (2007) demonstrated that HCMV pUL52 is another
essential protein for cleavage and packaging [14]. It is hypothe-
sized that pUL52 may be involved in the closing procedure of the
capsid after the DNA is encapsidated. However, it is most likely
that several additional viral proteins are required for the complex
DNA packaging process. One candidate is the protein UL77
(pUL77), a conserved core gene of HCMV. Analysis of deletion
mutants provided evidence that this protein is essential for HCMV
replication in fibroblasts [15,16]. The herpes simplex virus type 1
(HSV-1) homolog, pUL25, is part of a so-called capsid-vertex-
specific component (CVSC), an elongated molecule that is
localized on the outer surface of capsids whereas five copies
surround the capsid vertices [17].The protein has been shown to
be situated at multiple sites on the surface of capsids adjacent to
the pentons at the vertices [18,19]. Further analysis revealed that
pUL25 of pseudorabies virus (PRV) and HSV-1 is required for
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the viral genome after penetration of the host cell [22]. However,
the function of HCMV pUL77 is so far unknown.
To investigate its role in DNA packaging pUL77 (i) was
identified in infected cells and extracellular virions, also (ii) its
interactions with viral DNA packaging proteins, a prerequisite of
its proposed function, and (iii) DNA binding abilities were
analysed. By in silico analysis a coiled-coil motif (CCM) at the N-
terminus of pUL77 was identified. Its role in oligomerization as
well as DNA binding was confirmed using a CCM-deletion
mutant pUL77DCCM in in vitro studies.
Methods
Cells and virus
Human foreskin fibroblasts (HFF; PromoCell, Germany) and
human embryonic kidney (HEK) 293T cells (ATTC, USA) were
grown in Dulbecco’s minimal essential medium (DMEM)
supplemented with 10% fetal calf serum (FCS), 2 mM glutamine,
penicillin (5 U/ml), and streptomycin (50 mg/ml). HFF cells at
passages 10 to 15 were used for infections and experiments were
carried out with confluent cell monolayers (1.5610
7 cells).
Infection of HFF with HCMV AD169 at a MOI of 3 was carried
out as described before [4].
Plasmid construction and oligonucleotides
Restriction enzymes were purchased from Fermentas (St. Leon-
Rot, Germany) and used as instructed by the manufacturer. The
UL77 gene was generated by PCR amplification from cosmid
pCM1075 [23] using the following pair of oligonucleotides
(restriction sites for EcoRI and XbaI or XhoI were underlined):
59-CGGAATTCTGATGAGTCTGTTGCACACCTTTTGG-
CGG-39 and
59-TCGGCTCGAGTTACAACACCGCCACGCTCGG-39 for
pGEX-UL77
or
59-GCGAATTCTGATGAGTCTGTTGCACACCTTTTGG-
CGG-39 and
59-GCTCTAGATTACAACACCGCCACGCTCGG-39 for myc-
UL77 and pcDNA-UL77
or
59-C A GAATTCATGCTCGACGAAGGACCGTCG-39 and
59-C A TCTAGATTACAACACCGCCACG TCGG-39 for
pcDNA-UL77DCCM
The PCR product as well as the vector pGEX-6P-1, pcDNA3.1
Myc and pcDNA3.1/His C (Invitrogen, Karlsruhe, Germany),
were separately digested with EcoRI and XbaI or XhoI, and the
PCR product was ligated in-frame into the vectors yielding pGEX-
UL77, myc-UL77, pcDNA-UL77 and pcDNA-UL77DCCM.
Constructs pcDNA-UL56 [18] and pcDNA-UL104 [14] were
designed for previous studies. Plasmid pHM123 encoding IE1 is
described by Plachter et al. [24].
Purification of GST-UL77 and PreScission treatment
A fresh overnight culture of E. coli BL21 carrying the plasmid
pGEX-UL77 was grown in LB media. After the cells reached an
OD600 of 0.5 the GST-protein expression was induced by addition
of isopropyl-1-thio-ß-D-galactopyranoside (IPTG) to a final
concentration of 0.1 mM and incubated for 2 h at 37uC.
Sedimented cells were lysed in 40 ml binding buffer (20 mM
sodium phosphate, 0.15 M NaCl, pH 7.4) containing 250 mM
MgCl2,2 5 mM MnCl2, 400 mg DNase I and 4 mg lysozyme,
incubated for 30 min and sonicated on ice. Undissolved material
was sedimented at 5.0006 ga t4 uC and supernatant passed
through a 0.2 mm filter. The purification was performed with a
GSTrap
TM column (1 ml bed volume) by using an A ¨KTA FPLC
(GE Healthcare, Freiburg, Germany) according to the instruction
of the manufacturer. The column was washed with three bed
volumes binding buffer prior to loading the proteins.
Protein is eluted from the column with 10 bed volumes of elution
buffer (50 mM Tris-HCl, 10 mM reduced glutathione, pH 8.0) and
used in cross-linking experiments and in vitro binding assays.
For usage as antigen in antibody purification GST-tag needs to
be removed. To cleave the GST tag from GST-UL77, the bound
protein was incubated with 80 units of PreScission protease (GE
Healthcare, Freiburg, Germany) for 12 h at 4uC. After removal of
the GST tag the resulting protein was eluted in 10 fractions (1 ml)
of PreScission buffer (50 mM Tris-HCl pH 7.0, 150 mM NaCl,
1 mM EDTA, 1 mM DTT). The fractions containing the protein
rpUL77 were stored at 280uC.
Antibody against pUL77
HCMV pUL77 specific human polyclonal antibody pAbUL77
was purified from high titer human serum (IgG positive patient
serum selected by CMV diagnostic) by column affinity chroma-
tography (Affigel 10/15-pUL77). Affinity purification was per-
formed as described previously [11]. The specificity of the purified
pAbUL77 was determined using immunoblots with rpUL77.
Immunoblot strips were reacted with Cytotect (Biotest, Germany),
a hyper immune serum against HCMV (HCMV
+, 1:500; Fig. 1A,
lane 1), CMV pp52 (CH16; Santa Cruz Biotechnology, Heidel-
berg, Germany) monoclonal antibody against pUL44 (mAbUL44;
Fig. 1A, lane 2) and pAbUL77 (Fig. 1A, lane 3). Only Cytotect and
the purified antibody pAbUL77 reacted on strips with rpUL77. As
an additional control for specificity of pAbUL77 immunoblot
analyses with different viral proteins were performed. Immunoblot
stripes (kindly provided by Mikrogen Diagnostic, Neuried,
Germany) containing recombinant polypeptides encoding imme-
diate early protein 1 (IE1; 53 kDa), tegument protein pp150
(50 kDa), processivity factor pUL44 and single stranded binding
protein pUL57 (45 kDa), tegument protein pp65 (31 kDa),
glycoprotein B (gB1, 25 kDa; gB2, 18 kDa) only reacted with
reconvalsecent serum (Fig. 1B, lane 1) and specific antibody
against pUL44 (Fig. 1B, lane2). These observations demonstrate
that pAbUL77 is a monospecific antibody against pUL77.
Isolation and fragmentation of HCMV extracellular virions
Four days after infection extracellular virions were separated
from dense bodies and non-infectious enveloped particles (NIEPs)
by sedimentation through a sodium-tartrate gradient according to
Talbot and Almeida [25]. Isolated virions were incubated with
non-ionic detergent (1% (v/v) NP-40) for 10 min on ice prior to
separation through a 15% (w/v) sucrose cushion in TE buffer
(100.0006g,1ha t4 uC). The supernatant contains the envelope
fraction. The sediment which constitutes the capsid/tegument
fraction was treated with 1% (v/v) ß-mercaptoethanol for 10 min
on ice. Following this treatment, the capsid/tegument fraction was
loaded onto a 15% (w/v) sucrose cushion and sedimented
(100.0006g,1ha t4 uC). The supernatant contains the tegument
and the sediment the capsid fraction. The tegument as well as the
envelope fraction were precipitated by 10% (v/v) TCA and
dissolved in TE buffer. The capsid, tegument and envelope
fraction as well as mock-, infected cells and extracellular virions
were subjected to SDS-PAGE prior to immunostaining.
Immunoprecipitation
For immunoprecipitation HCMV AD169 infected or mock-
infected cells (T-75 cm
2 flasks; 2610
6 cells) were 60 h post
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35S] methionine for
12 h. Total cell extracts were prepared from labelled cultures by
solubilisation in immunoprecipitation buffer (20 mM Tris-HCl
pH 7.5, 100 mM NaCl, 1% NP-40, 5 mM EDTA, 25 mM
iodacetamide, 0.4% sodiumdeoxycholate, 1 mM PMSF, 100 U/ml
Trasylol)andultrasonic treatment.Insolublematerialwassedimented
for 30 min at 100.0006ga n d4 uC. Comparable amounts of extracts
and pUL77-specific antibody pAbUL77 (1:5) were used for
precipitation prior to SDS-PAGE and autoradiography [6].
For co-immunoprecipitation either HFF cells (2610
6) were
infected with HCMV AD169 (MOI 2) or 293T cells (2610
6) were
transfected with (i) myc-UL77 and pcDNA-56, (ii) myc-UL77 and
pcDNA-MCP , (iii) myc-UL77 and pcDNA-UL104, (iv) myc-
UL77 and pHM123 (IE1). Total cell extracts were prepared 72 h
after infection or 48 h after transfection by solubilisation in co-
immunoprecipitation buffer (20 mM Tris-HCl pH 7.5, 150 mM
NaCl, 0.5% Tween, 5 mM EDTA) containing the protease
inhibitor mix M (Serva, Heidelberg, Germany) prior to ultrasonic
treatment. Insoluble material was sedimented for 10 min at
100.0006 g. Comparable amounts of extracts were used for
precipitation. For mock-infected or infected cells pAbUL77 (1:10)
as well as specific antibody pAbUL56 specific for pUL56 [5],
pAbUL104 specific for pUL104 [11], mAb63-27 specific for IE1
and mAb28-4 specific for the major capsid protein (MCP; 1:10)
were used for precipitation from both sides.
To analyse if protein- protein interactions are observed with
solitary expressed proteins, pUL77 was precipitated using specific
Myc-Tag antibody (1:500; Cell Signaling) in co- transfection
experiments. Exact procedure was described previously [6].
Immunoprecipitates were analyzed by SDS-PAGE followed by
immunoblotting.
PAGE and immunoblot analysis
Extracts from mock-infected, infected cells or immunoprecip-
itates were solubilzed in 46 sample buffer [4% (v/v) ß-
mercaptoethanol, 0.01% (w/v) bromphenol blue, 4% (w/v)
glycerol, 4% (w/v) SDS, 0.2 M Tris-HCl (pH 6.8)] prior to
separation on 8 or 10% (w/v) sodium dodecyl sulfate-polyacryl-
amide gel. Proteins were transferred to nitrocellulose sheets and
subjected to immunoblot analysis as described previously [26].
The antibody pAbUL77, pAbUL56 specific for pUL56 [5],
pAbUL104 specific for pUL104 (14), mAb63-27 specific for IE1
and mAb28-4 specific for the major capsid protein (MCP; 1:10),
were used as the primary antibodies. To analyze purified
extracellular virions and the separated capsid fractions, pAbUL77,
CMV pp28 (5C3; (1:500;Santa Cruz Biotechnology, INC.,
Heidelberg, Germany) specific for the tegument protein pp28,
mAb27-156 (1:10) specific for the glycoprotein B and mAb28-4,
served as primary antibodies, respectively.
For detection of primary antibody binding, horseradish
peroxidase-conjugated anti-human or anti-mouse F(ab9)2 frag-
ments (1:5000 in PBS with 0.3% BSA; Abcam, Cambridge,
United Kingdom) and the ECL (Super Signal West Pico) reagent
were used as recommended by the supplier (Pierce; Thermo Fisher
Scientific, Germany).
In vitro translation
The plasmids pcDNA-UL77, pcDNA-UL77DCCM, pcDNA-
UL56 or pcDNA-MCP (1 mg each) were incubated with [
35S]
methionine/cystein (10 mCi/ml) and 40 ml TNTH T7 Quick
Master Mix (Promega, Mannheim, Germany) in a final volume of
50 ml for 1.5 h at 30uC. Translation products were analyzed by
8% SDS-PAGE or subjected to DNA binding assay without any
sedimentation step.
Nuclear extracts for DNA binding analysis
For preparation of cells extracts for DNA binding analysis HFF
cells (1610
7) were infected with HCMV AD169 (MOI 5). The
method used for extraction has been described before [5]. Briefly, at
72 h p.i. infected and mock-infected extracts were harvested and
stored at 280uC. Frozen cell extracts were prepared by solubilisa-
tion in 10 volumes buffer A (20 mM Hepes pH 7.9, 10 mM KCl,
1.5 mM MgCl2) with protease inhibitors (Complete) and allowed to
swell for 20 min at 4uC. After sedimentation (1.000 g,4 uC, 10 min)
the cells were resuspended in 4 volumes buffer A with protease
inhibitors and lysed with 30 strokes in a Dounce homogenizer (B
pestle). Nuclei were sedimented and resuspended in 1.5 volumes
buffer C (20 mM Hepes pH 7.9, 1.5 mM MgCl2, 0.42 mM NaCl,
20%(v/v)glycerol) with the same proteaseinhibitorsas forbufferA.
The salt extraction was performed for 30 min on ice. After
centrifugation, the supernatant was dialyzed against DNA-binding
buffer (50 mM Tris-HCl pH 8.0, 10% glycerol, 1 mM DTT,
1 mM EDTA), followed by centrifugation of insoluble material.
The nuclei were frozen in aliquots at 280uC.
DNA Binding Assay
In vitro DNA binding analysis was performed as described before
[11]. Briefly, DNA-cellulose (Sigma-Aldrich) or matrix material
Figure 1. Characterization of the antibody pAbUL77. (A) Purified
GST-UL77 was separated by 10% SDS-PAGE and transferred to
nitrocellulose. Immunoblot strips were reacted with hyper immune
serum Cytotect (HCMV
+ Serum, lane 1), anti-pUL44 (mAbUL44, lane 2)
and pAbUL77 (lane 3). (B) Immunoblot stripes containing recombinant
proteins encoding immunodominant epitopes of IE1 (53 kDa), pp150
(50 kDa), pUL44/pUL57 (45 kDa), pp65 (31 kDa), gB1 (25 KDa) and gB2
(18 kDa) were reacted with hyper immune serum (HCMV
+ Serum, lane
1), anti-pUL44 (mAbUL44, lane 2) and pAbUL77 (lane 3). Control stripe
incubated with a weak HCMV+ serum from Mikrogen Diagnostics was
shown on the right. Arrows on the right side indicate the position of
pUL77. Molecular weight markers (M) are shown on the left side.
doi:10.1371/journal.pone.0025115.g001
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with [
35S]-labeled pUL77, MCP, HSV-1 ICP8 or pUL56 diluted
1:10 in DNA binding buffer (DBB; 50 mM ‘Tris-HCl, pH 8.0,
10% glycerol, 1 mM DTT, 1 mM EDTA). Bound protein was
eluted in 0.5 ml fractions of DBB with increasing concentrations of
NaCl (200, 400, 800, 1500 and 2000 mM). Fractions were
subjected to 8% SDS-PAGE prior to autoradiography.
Sequence specific binding to ds oligonucleotides
This assay (Fig. S2) is modified from the DNA binding assay
described above.
50 ml Avidin resin (Thermo Scientific, Dreieich, Germany) was
equilibrated in 250 ml PBS +1% Nonidet P-40 for 2 h at room
temperature. In the following 59-end biotinylated oligonucleotides
(1 mg/ml) and their complementary strand (1 mg/ml; Invitrogen)
were purified, combined, denatured at 95uC for 2 min and
annealed at 55uC for 30 minutes.
59-ATTTCACCCCCCCGCTAAAAACACCCCCCCGCCC-
AC-39 bio-pac1 for and
59-GTGGGCGGGGGGGTGTTTTTAGCGGGGGGGTG-
AAAT-39 pac1 rev yielded the double stranded 36-mer oligonu-
cleotide bio-pac1. In addition, a 250-, 500- and 1000-mer
biotinylated DNA fragment containing pac1 motif were obtained
by PCR prior to gel purification (PureLink Quick Gel Extraction
Kit; Invitrogen) using pUC-aseq [7] as a template and the
following primer:
59-CGTGCACACAGCCCAGC-39 bio-250 bp,
59-CTACCAGCGGTGGTTTGTTTG-39 bio-500 bp and
59-AATTAATAGACTGGATGGAGGCGG-39 bio-1000 bp.
59-ATTTCACCCCCCCGCTAAAAACTCCGCCCCCCTG-
ACGAG-39 as reverse primer for all three amplifications.
Furthermore, a specific HCMV 966–mer biotinylated oligonu-
cleotide encoding a region between the L/S-junction were
obtained by PCR using plasmid pON205 (kindly provided by
E.S. Mocarski) with the following primer:
59- CTGGTACCGGCGCGCCCAAAAAG- 39 bio-HCMV
and
59- CTCGAGCGCTGTCATCTAGGTG-39 HCMV reverse
primer
The bio-250 bp, bio-500 bp, bio-1000 bp and bio-HCMV
double-stranded oligonucleotides were only used for analysis with
pUL77, while the 36-mer bio-pac1 was used for pUL77 as well as
for pUL56 and MCP. The biotinylated double-stranded oligonu-
cleotide was bound to the avidin resin by incubation for 30 min at
room temperature. For removing excess unbound oligonucleotides
the resin was washed twice with PBS +1% Nonidet P-40. The resin
was dissolved in 100 ml PBS +1% Nonidet P-40, 20 mlo fin vitro
translated protein pUL77, pUL56 or MCP (see above) were added
and incubated at 4uC over night. After additional washing steps
(50 mM Tris-HCl pH 8.8, 10% glycerol, 1 mM DTT, 1 mM
EDTA, 150 mM NaCl) bound DNA-protein complexes were
eluted by a sodium chloride gradient (200 mM-2000 mM NaCl)
prior to boiling in SDS sample buffer. Samples were analyzed by
8% SDS-PAGE followed by autoradiography. Radioactive signals
were analyzed using BioImager (Fuji, Raytest, Straubenhardt,
Germany) and quantified with the image processing program
ImageJ 1.41o (National Institute of Health, USA).
Chemical cross-linking
Either purified rpUl77 or in vitro translated, radiolabeled pUL77
or pUL77DCCM were incubated 5 min at room temperature in
PBS in a final volume of 20 ml. The cross-linking reaction was
started by addition of 0.1% glutaraldehyde to a final concentration
of 0.01%. The reaction was stopped by addition of 10 ml sodium
dodecyl sulfate (SDS) loading buffer and denaturation of the
samples for 2 min at 95uC. The proteins were separated by 8%
SDS polyacrylamide gel electrophoresis (PAGE) and analyzed by
autoradiography.
In vitro binding assay
For in vitro binding analysis, equal amounts of GST fusion
proteins pUL77-GST (see above) loaded on glutathione-sepharose
4B (Amersham Bioscience) were incubated with in vitro translated
pUL77 or pUL77DCCM for 2 h at 4uC in 500 ml binding buffer
(0,05% Nonidet P-40; 50 mM Hepes, 10% glycerol; 0,1% BSA;
300 mM NaCl; pH 7,3). Samples were washed with binding
buffer and subsequently subjected to SDS-PAGE, consecutive
fixation and autoradiography. The autoradiogram was quantita-
tively analysed using image processing software ImageJ 1.41o
(National Institute of Health, USA).
Sequence analysis
For secondary structure prediction PSIPRED (http://bioinf4.cs.
ucl.ac.uk:3000/psipred) was used. For determination of putative
oligomerization domains (coiled-coil motif (CCM) analysis) the
following prediction programs were used:
PCOILS (http://toolkit.tuebingen.mpg.de/pcoils),
NPS (http://npsa-pbil.ibcp.fr/cgi-bin/secpred_consensus.pl),
COILS (http://www.russelllab.org/cgi-bin/coils/coils-svr.pl),
MATCHER (http://cis.poly.edu/,jps/matcher.html) and
Marcoil (http://www.isrec.isb-sib.ch/cgi-bin/BCF/webmarcoil/
webmarcoilC1.cgi).
Results
Identification of the protein UL77
In order to identify the protein UL77, HFF cells (2610
6)
infected or mock-infected with HCMV AD169 (MOI 1) were
radiolabeled with 50 mCi/ml [
35S]methionine at 60 h p.i. for 12 h
and subjected to immunoprecipitation with pUL77 specific
pAbUL77 (Fig. 2A). In AD169 infected cell extracts two proteins,
a prominent one representing the 70 kDa monomer and a faint
one of approximately 140 kDa, were precipitated while no protein
was detected in the control (Fig. 2A). The molecular mass of
approximately 70 kDa corresponds to the calculated mass of
pUL77 (71 kDa) whereas the high molecular mass form might
represent an oligomer of pUL77.
To further characterize pUL77 extracts of HCMV AD169
infected or mock-infected HFF cells were subjected to SDS-PAGE
prior to immunoblot analysis. Interestingly, only a protein with a
size of a pUL77 monomer was recognized by the monospecific
antibody pAbUL77 (Fig. 2B), which may be due to a lower
sensitivity of immunostaining. Identical extracts were subjected to
native PAGE followed by immunoblot analysis with pAbUL77.
Under these conditions only one higher molecular weight protein
was detected, thus indicating that the monomer and the oligomer
are transcribed from UL77 (Fig. 2C).
Association of pUL77 with capsids
To determine whether pUL77 is a structural component of
virions the three virion fractions (i) envelope, (ii) tegument and (iii)
capsid were separated by ultracentrifugation. Virions were purified
from the supernatant of HCMV AD169 (MOI 3) infected HFF by
sedimentation. Purification of fractions was analyzed by immuno-
blots using antibodies against the major capsid protein MCP,
tegument protein pp28 or glycoprotein B (Fig. 2D). MCP served as
a control of equal protein amounts in virion and capsid fractions as
well as an indicator for the purification of the capsid fraction
Oligomerization and DNA Binding via pUL77 CCM
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separated with the capsid fraction (Fig. 2D, lane 6). The control
protein gB indicating envelope fraction was detected both in virion
and envelope fraction (Fig. 2D, lanes 3–4). Further indicating
purity of fractions pp28 was detected only in the virion and
tegument fraction (Fig. 2D, lanes 3, 5). These results suggest that
HCMV pUL77 is associated with the capsid.
Discovery of CCMs in pUL77
In order to analyze the ability of pUL77 to form oligomers in
silico analysis were performed. The presence of coiled-coil motifs
(CCM) in the amino acid sequence was confirmed with the
statistical analysis program PCOILS (Fig. 3A) using the weighting
option and the profile matrix MTIDK. Coiled-coil structures are
built by at least two alpha-helices that dimerize forming a supercoil
[27] CCMs consist of regular alternation of three or four heptad
repeat elements. The individual positions of the amino acids (aa)
are labelled a–g, whereas a and d represents hydrophobic aa, e
and g polar or charged aa. The probability of pUL77 showed for
all scanning windows one region at the N-terminus that can form
coiled-coil structures (Fig. 3C, upper panel). In this region at least
three heptads were predicted in scanning window-14 and two in
Figure 2. Identification of the UL77 gene product. (A) HCMV infected (lane 2) or mock-infected cells (lane 1) were 60 h p.i. radiolabeled with
50 mCi/ml [
35S]methionine for 12 h. Cells were harvested and subjected to immunoprecipitation with pAbUL77 prior to 8% SDS-PAGE and
autoradiography. (B) Extracts from mock-infected (lane 1) or HCMV-infected cells (lane 2) were used for immunoblot analyses with antibody pAbUL77
prior to 8% SDS-PAGE. The asterisks (*) indicates degradation products. Arrows on the right side indicate the positions of the monomer of pUL77 and
an oligomer, while the molecular weight markers (M) are indicated on the left. (C) Extracts from mock-infected (lane 1) or HCMV-infected cells (lane 2)
were subjected to 8% native gel electrophoresis followed by immunoblot analysis with pAbUL77. Marker proteins were a-carbonic anhydrase (a-CA,
29 kDa), ovalbumin (OVA; 45 kDa), BSA (66 kDa), phosphorylase b (PYG; 97 kDa) and ß-galactosidase (ß-Gal; 116 kDa). D) Association of pUL77 with
viral capsids. (A) Mock- (lane 1) and infected cell extracts (lane 2) as well as extracellular virions (lane 3), envelope (lane 4), tegument (lane 5) and
purified capsid (lane 6) fractions were analyzed by immunoblot with pAbUL77 and, antibodies against MCP (capsid), pp28 (tegument) or gB
(envelope). The asterisks (*) indicates degradation products. The molecular weight standards (M) are indicated on the left side, the proteins are
indicated by arrows.
doi:10.1371/journal.pone.0025115.g002
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addition, secondary structure analysis by PSIPRED revealed an
alpha helix along this region. Even though the prediction of CCMs
were done by using the to date most reliable program PCOILS
[28], additional analysis were performed with four other programs.
Predictions from the NPS server were identical while the COILS,
MATCHER, Marcoil programs resulted in a moderate prediction
(Fig. S1). These results indicated that 100 amino acids of the N-
terminus of pUL77 have the ability to form coiled-coil structures.
In contrast to wild type pUL77 the N-terminally truncated
pUL77DCCM (Fig. 3A) shows no probability to form CCM as
predicted by PCOILS (Fig. 3C, lower panel). This missing coiled-
coil motif indicates that this mutant might loss the ability to
oligomerize. This hypothesis was tested in the following in vitro
experiments.
Influence of CCM deletion on oligomerization
To determine the ability to form oligomers purified protein
rpUL77 expressed from baculovirus was examined by chemical
cross-linking. The protein was treated for 0, 0.5, 2, 5, 10 and
15 min with glutaraldehyde prior to separation by SDS PAGE
and detection via immunostaining. Cross-linking of rpUL77
resulted in electophoretic mobility shift, indicating the formation
of dimers after approximately 10 min of incubation on ice (Fig. 4A,
lane 5). In comparison, using the same approach with pUL104,
dimers as well as multimers could be detected [29]. This result
showed that pUL77 is able to assemble into dimers without the aid
of additional viral proteins.
To investigate the ability of dimer formation further, in vitro
translated, radiolabeled pUL77 or pUL77DCCM were examined
by the identical cross-linking procedure. After treatment with
glutaraldehyde and separation by SDS PAGE the detection was
performed by autoradiography. Cross-linking of wild-type pUL77
(Fig. 4B lane 1–4) leads to a band of higher molecular weight after
10 min glutaraldehyde treatment, which corresponds to the size of
a dimer, whereas no oligomer was observed in probes containing
the mutant pUL77DCCM (Fig. 4B lane 5–8). Taking together
these two results suggest that the coiled-coil domain is a
prerequisite for the ability of pUL77 to form homodimers.
Interaction of HCMV pUL77 with DNA packaging proteins
In order to investigate direct interactions between pUL77 and
capsid-associated proteins analysis in the viral context were
performed using mock-infected or HCMV AD169 (MOI 2)
infected cells. For co-immunoprecipitations either the monospe-
cific antibody against pUL77 (Fig. 5A) or against IE1, pUL56,
pUL104 and MCP (Fig. 5B) were used. The following immuno-
staining detected pUL56 as the full size protein of 130 kDa
(Fig. 5A, pUL56), MCP at 145 kDa (Fig. 5A, MCP), the monomer
of pUL104 at 70 kDa (Fig. 5A, pUL104) and pUL77 to analyze
the presence of both precipitated proteins (Fig. 5A, pUL77) in
HCMV-infected cell extracts and co-immunoprecipitates. No
protein was detected in mock-infected cell extracts or co-
immunoprecipitates (Fig. 5A, lanes 1, 3). Immunostaining against
IE1 was used as a negative control (Fig. 5B, lane 4, IE1). In
addition, precipitations using antibodies specific for pUL56,
pUL104, MCP and IE1 detected pUL77 in the corresponding
manner, thus confirming the interactions (Fig. 5B).
To further examine whether interactions between pUL77 and
packaging proteins are obtained with solitary expressed proteins
co-immunoprecipitation in 293T-transfected cells were performed.
For precipitation Myc-tag antibody prior to immunostaining
against Xpress tag of IE1, pUL56, pUL104 and MCP was used. In
precipitates monomers of pUL56, pUL104 and MCP were
detected (Fig. 5C, lanes 8, 10, 12). In precipitates of vector-
transfected cell extracts as well as IE1-transfected cells no specific
proteins were observed (Fig. 5C, lane 4, 6).
These data implicate physical interactions between the capsid-
associated pUL77 and the structural proteins of the HCMV capsid
(i) the large terminase subunit pUL56, (ii) the portal protein
pUL104 and (iii) MCP.
DNA binding of HCMV pUL77
To determine the ability of pUL77 to bind dsDNA, in vitro
bindingstudieswereperformed.RadiolabeledpUL77(Fig.6A(i))or
MCP as a negative control (Fig. 6A (ii)) or HSV-1 ICP8 (Fig. 6A (iii)
and pUL56 (Fig. 6A (iv)) as positive controls were loaded on a
dsDNA cellulose column. After the washing steps bound proteins
were eluted with a sodium chloride gradient. Eluates were analyzed
by SDS-PAGE and autoradiography. pUL77 as well as both
positive controls pUL56 and ICP8 could be detected in the eluted
fractions (Fig. 6A (iii–iv)) thus implying an interaction with dsDNA.
In contrast to this observation there was no significant signal for
MCP (Fig. 6A (ii)). In addition, binding of pUL77 to heparin was
analysed, because its negative charge mimics the electrostatic
characteristics of dsDNA and therefore heparin-sepharose is used to
bindDNAbindingproteins. Invitro translated pUL77 was loadedon
a heparin sepharose and eluted as described above. The proteinwas
detected in the eluted fraction (Fig. 6A (v)). To determine whether
pUL77 from infected cells binds to DNA, nuclear extracts were
prepared for dsDNA cellulose binding assay. A band representing
pUL77 as well as a degradation product were detected in the eluted
fractions by the monospecific antibody (Fig. 6B). These results
demonstrated that pUL77 can bind to dsDNA.
HCMV pUL77 binds to dsDNA with sizes of at least
500 bp
To analyze whether pUL77 has the ability to bind to the pac 1
motif or certain DNA fragments, double-stranded 36-mer
oligonucleotides as well as 250, 500, 1000 bp and a HCMV-
specific 966 bp (bio-HCMV) fragments with incorporated biotin
were bound to avidin agarose resin prior to incubation with
in vitro translated, radiolabelled pUL77 (Fig. 7A, (I)–(V)) or
pUL77DCCM (Fig. 7A, (VI)), pUL56 (Fig. 7B, lane (II)) or
MCP (Fig. 7B, (III)). The resin was subjected to sequential washing
steps prior and after binding of in vitro translated proteins and
elution steps (Fig. 7, lanes 2–8). Thus, pac 1 motif alone is not
sufficient for binding (Fig. 7A (I)) nor oligonucleotides smaller than
500 bp (Fig. 7A (II)). However, binding of pUL77 was observed if
the oligonucleotides bio-500 bp, bio-1000 bp DNA or bio-HCMV
were used (Fig. 7A (III)–(V)). In order to interpret the findings
intensity of signals were quantitatively analysed. The binding
efficiency (BE) determined by image processing software was
2.260.41 for bio-500 bp and 4.960.72 for bio-1000 bp, respec-
tively (Table 1). In contrast, the terminase subunit pUL56 showed
a sequence specific binding to bio-pac1 with a BE of 10.060.63
(Fig. 7B (II), lane 8; Table 1). By using the negative control MCP
no signal was detected (Fig. 7B (III), lane 8; Table 1). No binding
was observed using pUL77DCCM (Fig. 7A (VI)). The complete
deletion of the CCM negatively influences pUL77-associated
DNA binding to biotinylated 1000 bp dsDNA. These data
indicates that pUL77 is able to bind to dsDNA with a size of at
least 500 bp or longer in a non pac 1 motif specific manner.
Discussion
Viral packaging and subsequent cleavage of concatemeric
DNA into genome units are multifunctional steps in which several
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at least seven proteins, the gene products of UL6 [30–33], UL15
[34,35], UL17 [36,37], UL25 [38,39], UL28 [34,40], UL32 [41]
and UL33 [42], are required for DNA cleavage and packaging.
Homologous proteins are found in HCMV, but the mode of
action of each protein is not known to date and has to be
elucidated.
In the present study the HCMV protein UL77 (pUL77) [43],
the structural homolog to HSV-1 and PrV pUL25, which is
required for viral replication, was characterized. Analyses were
performed with an affinity-purified antibody against pUL77. In
HCMV infected cells pUL77 has a molecular mass of approxi-
mately 70 kDa with a tendency to form oligomers. In infected cells
the observed oligomer could be a heterodimer of pUL77 and
pUL93, the homologue of pUL17 of HSV-1 [36,37]. However,
our results with purified solitary expressed rpUL77 as well as in
vitro translated protein implicates that pUL77 has the ability to
form a homodimer. Our data are in line of the recently reported
data from To et al [44] demonstrating by yeast two hybrid analysis
and co-immunoprecipitation that pUL77 could form homodimers.
Figure 3. Coiled-coil motifs and secondary structure predictions of pUL77. (A) Schematically drawing of wild type pUL77 and N-terminally
truncated pUL77DCCM, both used in this study. Position of CCM between aa 47 and aa 100 is indicated by the grey box. (B) pUL77 sequence between
aa 47 and aa 100. The heptad frame (abcdefg) for scoring the CCM probabilities are shown underneath, while the secondary structure prediction by
PSIPRED (http://bioinf4.cs.ucl.ac.uk:3000/psipred) is shown above the aa of pUL77. Probability scores (9 is 100%) in the scanning window 14 and 21, in
the region between aa 47 and aa 100 are shown below the sequence. The first two heptads (red and blue) are predicted in both scanning windows.
(C) Probability blot for the CCMs predicted by PCOILS (http://toolkit.tuebingen.mpg.de/pcoils). Probability scores on a scale of 0 to 1 (1 is 100%) are
plotted against aa residue number of pUL77 and pUL77DCCM. Peaks in the figure indicate regions of higher coiled coil probability. MTIDK scoring
matrix with weighted options was used. The default output of probabilities in the scanning windows of 14, 21 and 28 aa residues are shown in green,
blue and red. One region between aa 77–91 is predicted to form coiled-coil structure. The inset shows a schematic drawing of the pUL77 protein.
doi:10.1371/journal.pone.0025115.g003
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e a r l i e r[ 4 5 ] ,t h eo l i g o m e rf o r m a tion in the virus could possible
be mediated via disulfide bonds. Since the oligomer was
observed under denaturing/reducing conditions on a SDS-
polyacrylamide gel it is more likely that the oligomer formation
o c c u r sb yac o v a l e n tb i n d i n g .I n t e r e s t i n g l y ,B o w m a ne ta l .
suggested that the N-terminal 133 residues of HSV-1 homolog
pUL25 could oligomerize via a coiled-coil interaction [46].
Sequence analysis using the statistical program PCOILS
predicted the presence of a coiled-coil motif (CCM) in the first
100 amino acids of pUL77. Experiments with a CCM deletion
mutant of pUL77 show that oligomerization was no longer
observed, thus indicating that CCM is required for oligomer
formation. The CCM is an oligomerization motif for many
proteins [27] including motor proteins, cytoskeleton proteins
and transcription regulators. All of these proteins form coiled-
coils for folding as well as oligomerization. These predications
are consistent with our in vitro d a t a .F u r t h e r m o r e ,s e c o n d a r y
structure analysis by PSIPRED predicted a long stretch of
helices in the CCM. Helices are thought to enhance the stability
of coiled-coil structures. Two of the most stable proteins are
tetrabrachion, a surface protein from archeabacterial and
Sendai virus phosphoprotein. Peters et al [47] reported that
tetrabrachion tetramers, stabilized by CCMs, could only be
denatured by 70% sulphuric acid or heating to 130uCf o r
30 min in 6 M guanidine hydrochloride. Regarding to our
results with the pUL77 CCM mutant it is reasonable to
hypothesize that the stability of the pUL77 oligomer under
denaturing/reducing conditions is due to the coiled-coil
structure.
The subviral localisation of pUL77 was examined by separation
of the capsid from purified virions prior to immunoblot analysis.
HCMV pUL77 oligomers were detected in purified extracellular
virions and capsids, thus demonstrating that pUL77 is a capsid-
associated structural protein. This is in agreement with several
observations with the homologous gene of HSV-1 and PrV [19–
21,48]. More recently, it has been suggested that the protein is
located at the vertexes of the capsid [17–19]. In addition, evidence
was provided that HSV-1 pUL25 is localized on the capsid surface
and might play a role in stabilization of capsids upon the increasing
pressure during DNA encapsidation [19,49,50]. It is reasonable to
speculate that this is as well a function of HCMV pUL77.
In order to verify the function of pUL77 as a capsid associated
DNA packaging protein studies concerning interactions with
packaging proteins were performed. Co-immunoprecitations of
infected cells as well as transfected cells demonstrated that HCMV
pUL77 interacts with the major capsid protein (MCP) as well as
the large terminase subunit pUL56 and the portal protein
pUL104. These physical interactions with the DNA packaging
motor components pUL56, in contrast to all other known
Figure 4. Influence of CCM deletion on dimerization. Recombinant expressed and purified (A) rpUL77 as well as in vitro translated (B) pUL77 or
pUL77DCCM was reacted with glutaraldehyde for the indicated times, followed by 8% SDS PAGE and immunoblot analysis. Molecular weight markers
(M) are indicated on the left side; position of the protein is indicated on the right.
doi:10.1371/journal.pone.0025115.g004
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capsid, and the portal protein pUL104 supports the proposed
function of pUL77 in anchoring DNA during encapsidation
[4,9,10].
Recent findings indicate that the homologous proteins do not
interfere with cleavage of concatemeric DNA but are involved in
later stages of packaging like providing a plug for the encapsidated
DNA [20,37,39]. In the case of HSV-1 it has been shown that a
UL25 null virus leads to an accumulation of A-capsids that lost
DNA during packaging [37]. Therefore another feature of these
proteins might be an at least short-term binding of DNA. To
support one or the other hypothesis it would be interesting to
Figure 5. Interaction to pUL77 with DNA packaging proteins. (A) Mock-infected or HCMV-infected HFF lysates at 72 h p.i. were co-
immunoprecipitated with pAbUL77 and subjected to SDS-PAGE prior to transfer onto nitrocellulose. Immunostaining was performed using
antibodies against IE1, pUL56, MCP, pUL104 and pUL77. (B) Mock-infected or HCMV-infected HFF lysates at 72 h p.i. were co-immunoprecipitated
with specific antibodies against IE1, pUL56, MCP and pUL104 and subjected to SDS-PAGE prior to transfer onto nitrocellulose. Immunostaining was
performed using pAbUL77 and as a control antibodies used for precipitation. (C) 293T cells were co-transfected with myc-UL77 and pcDNA3.1/HisC
(lanes 3–4), myc-UL77 and pHM123 encoding IE1 (lanes 5–6), myc-UL77 and pcDNA-UL56 (lanes 7–8), myc-UL77 and pcDNA-UL104 (lanes 9–10). or
myc-UL77 and pcDNA-MCP (lanes 11–12). 48 h after transfection co-immunoprecipitation was performed with specific mAb Myc-Tag and subjected
to SDS-PAGE prior to transfer onto nitrocellulose. Immunoblot analyses using specific mAb Anti-Xpress tag of pcDNA-UL56, pcDNA-UL104 and
pcDNA-MCP or using mAb3-27 for pHM123 was performed. The arrows indicate the positions of the proteins IE1, pUL56, MCP, pUL104 and pUL77
The molecular mass markers (M) are indicated on the left.
doi:10.1371/journal.pone.0025115.g005
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which is currently beyond the aim of this study.
None the less, short-term DNA binding would be a
prerequisite for both proposed functions. By using an in vitro
assay we demonstrated the ability of sequence-independent
DNA binding of pUL77. Our results are in line with the report
of Ogasawara [50] showing that HSV-1 pUL25 binds to
genomic DNA. In contrast to the terminase subunit pUL56 the
binding was only observed with the 500- and 1000-meric
dsDNA. One explanation of this observation could be due to the
different functions of the proteins. While the sequence specific
pUL56 mediated DNA-binding is required for insertion into the
capsid, the association of pUL77 with DNA is more likely a
temporary stabilization. In addition, one could hypothesize that
t h eo b s e r v e de f f e c ti sd u et ot h en e g a t i v ec h a r g eo ft h eD N A .
The enlargement of DNA fragments will result in increasing
Figure 6. Interaction of HCMV pUL77 with DNA. (A) In vitro translated pUL77 (i), MCP (ii), HSV-1 ICP8 (iii), or pUL56 (iv) (lane 1) were applied to a
dsDNA cellulose column. After the column was washed, DNA-binding proteins were eluted with increasing NaCl concentrations (lanes 3–8). To verify
the DNA binding ability of pUL77 the protein was loaded onto a heparin column. The elution was performed as described above (3–8). Nuclear
extracts of infected HFF were applied to the dsDNA cellulose (lane1). Elution was performed with increasing NaCl concentrations as described above
(lanes 3–8). For detection of pUL77 immunoblot analysis using the monospecific pAbUL77 was performed. The asterisks (*) indicates degradation
products. Molecular mass markers (M) are indicated on the left; the positions of the proteins are indicated on the right.
doi:10.1371/journal.pone.0025115.g006
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5.73, the protein is charged negative at the used pH 7.3.
Therefore the observed effect is not unspecific due to a positive
charged protein. Furthermore, the binding to Heparin column
is a characteristic of DNA binding proteins. It would be
interesting to identify the DNA binding site. In order to get a
hint CCM analysis was performed. We demonstrated that DNA
binding was no longer observed in pUL77DCCM mutant
lacking the CCM, thus showing that oligomerization is a
prerequisite for DNA binding in this case. The observed
interaction with HCMV DNA implicated a potential function
of pUL77 during packaging. One possible explanation could be
that HCMV pUL77 plays a role in anchoring the encapsidated
DNA during the late stage of packaging. To this end, further
studies will need to be performed aimed at deepening our
understanding concerning the role of HCMV pUL77 in viral life
cycle.
Supporting Information
Figure S1 CCM predictions in pUL77 using different programs.
Predictions are rated on the basis of probability values; higher the
probability, stronger the prediction: ++++, strong; +++, moderate,
+, weak; 2, none.
(PPT)
Figure S2 Schematic diagram of the binding to biotinylated ds
oligonucleotides. (I) Biotinylated ds oligonucleotides were incubat-
ed with avidin resin. (II) Several washing steps to remove unbound
DNA. (III) Addition of radiolabeled in vitro translated protein. (IV)
Washing steps II to remove unbound protein prior to incubation at
20uC. (V) Elution via a sodium chloride gradient and heating to
95uC. (VI) Analysis by autoradiography.
(PPT)
Acknowledgments
C.S.M. is a member of the ZIBI graduate school. S. L. is a fellow from the
Sonnenfeld foundation. We acknowledge W. Britt (University of Alabama,
Birmingham) for providing monoclonal antibodies mAb28-4 and mAb27-
156, T. Stamminger (Virologisches Institut - Klinische und Molekulare
Virologie, Erlangen) for monoclonal antibody mAb63-27 and plasmid
pHM123 and E.S. Mocarski (Emory University School of Medicine) for
plasmid pON205. We gratefully acknowledge R. Schilf and I. Woskobjnik
for technical assistance and thank C. Priemer for assistance concerning cell
culture. E.B. thanks D. Kru ¨ger for continuing support.
Author Contributions
Conceived and designed the experiments: CSM PK-R AD EB. Performed
the experiments: CSM PK-R AD SL. Analyzed the data: CSM PK-R EB.
Contributed reagents/materials/analysis tools: EB. Wrote the paper: EB.
Figure 7. HCMV pUL77 binds to specific DNA. (A) The binding
reaction was carried out by incubation of dsDNA oligonucleotides 36-
mers containing pac1 motif ((I), lanes 1–8), 250-mer ((II), lanes 1–8), 500-
mer ((III), lanes 1–8), 1000-mer ((IV), lanes 1–8) and HCMV-specific 966-
mer ((V), lanes 1–8) with avidin agarose resin followed by addition of in
vitro translated pUL77 or pUL77DCCM to 1000-mer ((VI) lane 1–8). (B) In
order to control unspecific binding abilities of protein to bead material
pUL77 was incubated with avidin beads only ((I) lane 1–8). In addition,
the specificity of the method was investigated with known interactions.
To the 36-mers containing pac1 motif (lanes 1–8) on avidin beads in
vitro translated pUL56 ((II), lane 1) or MCP ((III)l, lane 1) were added as
positive and negative control. The resin was subjected to serious
washing steps (lanes 2–7). DNA-binding proteins were eluted by boiling
in SDS sample buffer (lanes 8). Samples were analyzed by 8% SDS-PAGE
and autoradiography. Molecular mass standards are shown to the left,
the positions of the proteins are indicated on the right.
doi:10.1371/journal.pone.0025115.g007
Table 1. Binding efficiency to double-stranded
oligonucleotides.
Protein dsOligonucleotide Binding Efficiency (BE)*
pUL56 bio-pac1 10.060.63
MCP bio-pac1 0.260.40
pUL77 bio-pac1 0.260.03
pUL77 bio-250 bp 0.560.45
pUL77 bio-500 bp 2.260.41
pUL77 bio-1000 bp 4.960.72
*BE=binding to resin
1/in vitro tanslate
16100; BE=1=positive
1adjusted to
100%.
Values were obtained from three independent experiments.
doi:10.1371/journal.pone.0025115.t001
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